Clinical Trial Update: Cerebroprotective Effect of Melatonin in Stroke [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating melatonin for cerebroprotective effects in acute ischemic stroke is reported as ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke Acute Ischemic
• Strokes Thrombotic

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Coordinación de Investigación en Salud, Mexico | Conditions: Stroke, Acute Ischemic, Strokes Thrombotic | Phase 3 | Status: UNKNOWN